Skin News and Research

RSS

Study sheds light on quantity of MRSA colonization, relationship between quantities at different sites

A new study from Rhode Island Hospital now sheds light on both the quantity of MRSA at different body sites and the relationship between the quantities at different sites.

6 Jan 2011

Scientists discover that skin cancer can spread to lungs through cell blocking activity

CANCER RESEARCH UK-funded scientists have discovered that skin cancer can spread to the lungs when a gene in an important cell communication pathway is blocked. The research is published in Cancer Cell.

6 Jan 2011

Winter depression is more common in women than men

As the winter months approach bringing holidays and good cheer, certain health issues may arise that women should have on their radar. From mental health issues like stress, depression and seasonal affective disorder (SAD), to physical concerns like skin care, the winter can certainly pack a punch.

6 Jan 2011

Smiths Medical introduces new implantable ports with CT identifiers

Smiths Medical, a leading global medical devices manufacturer, announced today that they have launched new implantable ports with CT identifiers for easy viewing using X-rays or CT scout scans.

5 Jan 2011

Study shows adolescents who were breastfed at birth have stronger leg muscles

Breast feeding new born babies has lots of advantages in the short and in the long-term for babies. A study has confirmed the recently discovered benefits, which had not been researched until now. Adolescents who are breast fed at birth have stronger leg muscles than those who received artificial milk.

5 Jan 2011

Study identifies sailing injuries

Just as the site for the 2013 America's Cup has been announced, a study from Rhode Island Hospital highlights that the sport isn't always smooth sailing. The study was published recently in the journal Wilderness and Environmental Medicine.

5 Jan 2011

DBV Technologies secures $25.5 million in Series C financing round

DBV Technologies, an emerging biotechnology company, announced today that it has secured $25.5 million (€19,4 million) in a Series C financing round. The round was co-led by new investors InnoBio Fund (managed by CDC Entreprises within FSI France Investment program) and Lundbeckfond Ventures.

5 Jan 2011

FDA approves ImmunoCellular Therapeutics IND amendment for ICT-107 Phase II clinical trial

ImmunoCellular Therapeutics, Ltd., a biotechnology company that is developing immune-based therapies for the treatment of various forms of cancer, today announced that the U.S. Food and Drug Administration (FDA) has approved the Company's Investigational New Drug (IND) amendment to conduct a Phase II clinical trial in the U.S. of ICT-107, the company's dendritic cell based cancer vaccine candidate for the treatment of glioblastoma multiforme (GBM).

4 Jan 2011

Hepatitis A scare at Long Island church

Health officials have warned that parishioners who received Holy Communion during Christmas Mass at a church on Long Island may have been exposed to hepatitis A and may need vaccinated as soon as possible. Particularly those who received Communion at the 10.30am and 12pm (local time) masses on December 25, 2010, at Our Lady of Lourdes Church in Massapequa Park should get the shots.

4 Jan 2011

Lifestyle changes between childhood and adulthood linked to high-risk cholesterol levels

Lifestyle changes between childhood and adulthood appear associated with whether an individual will maintain, improve or develop high-risk cholesterol levels, according to a report in the January issue of Archives of Pediatrics & Adolescent Medicine, one of the JAMA/Archives journals.

4 Jan 2011

Embryome Sciences announces $4M equity financing, changes name to ReCyte Therapeutics

BioTime, Inc. today announced a $4 million equity financing by its subsidiary, Embryome Sciences, Inc. Concurrent with the financing, Embryome Sciences will be renamed ReCyte Therapeutics, Inc. and will develop therapeutic products for cardiovascular and blood diseases. The new equity financing is being led by a $2.5 million investment by private investors and a $1.5 million investment from BioTime that valued ReCyte Therapeutics at a post money valuation of $60 million on a fully diluted basis.

4 Jan 2011

Vitamin D deficiency could be linked to development of certain autoimmune lung diseases

A new study shows that vitamin D deficiency could be linked to the development and severity of certain autoimmune lung diseases.

4 Jan 2011

Aging linked to changes in eye sockets, jaw bones

What makes us look older? Wrinkles and sagging result not just from changes in the skin, but also from aging-related changes in the underlying facial bones, according to a report in the January issue of Plastic and Reconstructive Surgery®, the official medical journal of the American Society of Plastic Surgeons (ASPS).

4 Jan 2011

Combe divests Cough/Cold, Skin Care and Foot Care businesses

Combe Incorporated, today announced that it has completed the sale of its Cough/Cold, Skin Care and Foot Care businesses.

3 Jan 2011

FDA authorizes Juventas' JVS-100 Phase II clinical trial for critical limb ischemia

Juventas Therapeutics, a clinical-stage regenerative medicine company developing novel therapies for cardiovascular disease, announces that the U.S. Food and Drug Administration (FDA) authorized commencement of a Phase II clinical trial evaluating the efficacy and safety of its lead product, JVS-100, for the treatment of critical limb ischemia (CLI).

3 Jan 2011

Tips to avoid allergy and asthma triggers at the gym

A New Year's resolution to get in shape is good news for your health. But if you have allergies or asthma, the hidden triggers at the gym may be bad for your condition.

30 Dec 2010

Low levels of microbe-killing molecules improve survival rate of people with CGD

Investigators at the National Institutes of Health have observed that the survival rate of people with a rare immunodeficiency disease called chronic granulomatous disease is greatly improved when even very low levels of microbe-killing molecules are present.

30 Dec 2010

Kennedy Krieger inagurates new clinic for AHO treatment and research

Kennedy Krieger Institute announced the opening of a new clinic for the treatment and research of Albright hereditary osteodystrophy (AHO), a rare genetic disorder affecting the bones, skin and hormone-producing tissues.

29 Dec 2010

Hormone enhanced meat taken off shelves at Coles

Hormonal growth enhancers banned three decades ago in Europe after being linked to health risks including breast cancer, kidney disease and birth defects are still being used in Australia to fatten beef, a federal farm chemical survey reveals.

28 Dec 2010

Researchers study relationship between MITF, ATF2 in melanoma development

Melanoma is one of the least common types of skin cancer, but it is also the most deadly. Melanocytes (pigment-producing skin cells) lose the genetic regulatory mechanisms that normally limit their number, allowing them to divide and proliferate out of control. One such regulator, called MITF, controls an array of genes that influence melanocyte development, function and survival.

24 Dec 2010

Skin News and Research

Study sheds light on quantity of MRSA colonization, relationship between quantities at different sites

Scientists discover that skin cancer can spread to lungs through cell blocking activity

Winter depression is more common in women than men

Smiths Medical introduces new implantable ports with CT identifiers

Study shows adolescents who were breastfed at birth have stronger leg muscles

Study identifies sailing injuries

DBV Technologies secures $25.5 million in Series C financing round

FDA approves ImmunoCellular Therapeutics IND amendment for ICT-107 Phase II clinical trial

Hepatitis A scare at Long Island church

Lifestyle changes between childhood and adulthood linked to high-risk cholesterol levels

Embryome Sciences announces $4M equity financing, changes name to ReCyte Therapeutics

Vitamin D deficiency could be linked to development of certain autoimmune lung diseases

Aging linked to changes in eye sockets, jaw bones

Combe divests Cough/Cold, Skin Care and Foot Care businesses

FDA authorizes Juventas' JVS-100 Phase II clinical trial for critical limb ischemia

Tips to avoid allergy and asthma triggers at the gym

Low levels of microbe-killing molecules improve survival rate of people with CGD

Kennedy Krieger inagurates new clinic for AHO treatment and research

Hormone enhanced meat taken off shelves at Coles

Researchers study relationship between MITF, ATF2 in melanoma development

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News